Updated August 23, 2026

Independent · Owner-operatedSubscribe

DEALSMM Board & Paper to acquire RDM Arnsberg carton board mill in GermanyEARNINGSTadalafil raises glaucoma risk by 22%, British Ophthalmology study findsDEALSBMMVF maintains CAD 0.07 monthly dividend as August 28 ex-dividend date approachesEARNINGSNvidia earnings, Kevin Warsh's Jackson Hole debut, and tariffs converge on a stock market rally that hasn't healedEARNINGSTarget's 3.8% comp gains look convincing. The valuation math is harder to argue.MACROWarsh's soothing act meets a credibility test as Jackson Hole approachesDEALSMM Board & Paper to acquire RDM Arnsberg carton board mill in GermanyEARNINGSTadalafil raises glaucoma risk by 22%, British Ophthalmology study findsDEALSBMMVF maintains CAD 0.07 monthly dividend as August 28 ex-dividend date approachesEARNINGSNvidia earnings, Kevin Warsh's Jackson Hole debut, and tariffs converge on a stock market rally that hasn't healedEARNINGSTarget's 3.8% comp gains look convincing. The valuation math is harder to argue.MACROWarsh's soothing act meets a credibility test as Jackson Hole approaches

Front Page/News/Markets

MarketsJuly 25, 2026

MannKind books $50 million. Most of it was already owed.

The case for MannKind Corporation's (Nasdaq: MNKD) $50 million private placement has a surface appeal: fresh institutional capital behind a company that just cleared an FDA milestone. The c

ByFarida Karam

Read2 min

TickersMNKD

Filed by NewsNovo

Source

sec.gov

Disclosure

Editorial. NewsNovo is independent. Nothing in this article is investment advice; treat figures and quotations as starting points for your own research.

← Back to all news

Related coverage

MannKind books $50 million. Most of it was already owed.

Read next

Short-term bond funds become the refuge as cash stalls and long bonds break down

JPMorgan Chase exits Polymarket over regulatory concerns

Goldman Sachs derivatives desk flags AI trade stall as investor focus shifts to complacency